Tau negative frontal lobe dementia at 17q21: Significant finemapping of the candidate region to a 4.8 cM interval

Molecular Psychiatry

Volumn 7, Issue 10, 2002, Pages 1064-1074

  Rademakers, R ^a   Cruts, M ^a   Dermaut, B ^a   Sleegers, K ^b   Rosso, S M ^c   Van den Broeck, M ^a   Backhovens, H ^a   Van Swieten, J ^c   Van Duijn, C M ^a,b   Van Broeckhoven, Christine ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Chromosomes, human, pair 17; Dementia; Frontotemporal lobar degeneration; Genetic linkage; Genome wide search; Microtubule associated protein tau; Mutation analysis

Indexed keywords

TAU PROTEIN;

ADULT; AGED; ARTICLE; BRAIN NERVE CELL; CELL INCLUSION; CHROMOSOME 17Q; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FAMILIAL DISEASE; FEMALE; FRONTAL LOBE; FRONTOTEMPORAL DEMENTIA; GENE MAPPING; GENE MUTATION; GENETIC LINKAGE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTRON; MALE; PHENOTYPE; PRIORITY JOURNAL; UNTRANSLATED REGION;

AGED; AMYLOID BETA-PROTEIN PRECURSOR; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; DEMENTIA; FEMALE; FRONTAL LOBE; GENE DELETION; GENETIC MARKERS; GENOME, HUMAN; HUMANS; MALE; MIDDLE AGED; PEDIGREE; TAU PROTEINS;

EID: 12244259054     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001198     Document Type: Article

References (47)

1. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704-706.
2. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 269: 973-977.
3. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995; 376: 775-778.
4. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375: 754-760.
5. Hutton M, Busfield F, Wragg M, Crook R, Perez-Tur J, Clark RF et al. Complete analysis of the presenilin 1 gene in early onset Alzheimer's disease. Neuroreport 1996; 7: 801-805.
6. Cruts M, van Duijn CM, Backhovens H, Van den BM, Wehnert A, Serneels S et al. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet 1998; 7: 43-51.
7. Campion D, Dumanchin C, Hannequin D, Dubois B, Belliard S, Fuel M et al. Early-onset autosomal dominant Alzheimer disease: Prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet 1999; 65: 664-670.
8. Collinge J. Human prion diseases and bovine spongiform encephalopathy (BSE). Hum Mol Genet 1997; 6: 1699-1705.
9. Houlden H, Baker M, Adamson J, Grover A, Waring S, Dickson D et al. Frequency of tau mutations in three series of non-Alzheimer's degenerative dementia. Ann Neural 1999; 46: 243-248.
10. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393: 702-705.
11. Poorkaj P, Grossman M, Steinbart E, Payami H, Sadovnick A, Nochlin D et al. Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch Neural 2001; 58: 383-387.
12. Rizzu P, van Swieten JC, Joosse M, Hasegawa M, Stevens M, Tibben A et al. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet 1999; 64: 414-421.
13. Finckh U, Muller-Thomsen T, Mann U, Eggers C, Marksteiner J, Meins W et al. High frequency of mutations in four different disease genes in early-onset dementia. Ann N Y Acad Sci 2000; 920: 100-106.
14. Morris HR, Khan MN, Janssen JC, Brown JM, Perez-Tur J, Baker M et al. The genetic and pathological classification of familial frontotemporal dementia. Arch Neural 2001; 58: 1813-1816.
15. Brown J, Ashworth A, Gydesen S, Sorensen A, Rossor M, Hardy J et al. Familial non-specific dementia maps to chromosome 3. Hum Mol Genet 1995; 4: 1625-1628.
16. Hosler BA, Siddique T, Sapp PC, Sailor W, Huang MC, Hossain A et al. Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. JAMA 2000; 284: 1664-1669.
17. van Duijn CM, Hendriks L, Farrer LA, Backhovens H, Cruts M, Wehnert A et al. A population-based study of familial Alzheimer disease: Linkage to chromosomes 14, 19, and 21. Am J Hum Genet 1994; 55: 714-727.
18. Roks G, Dermaut B, Heutink P, Julliams A, Backhovens H, Van de BM et al. Mutation screening of the tau gene in patients with early-onset Alzheimer's disease. Neurosci Lett 1999; 277: 137-139.
19. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
20. Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; 337: 1158-1159.
21. Benson G. Tandem repeats finder: A program to analyze DNA sequences. Nucleic Acids Res 1999; 27: 573-580.
22. Ott J. Computer-simulation methods in human linkage analysis. Proc Natl Acad Sci U S A 1989; 86: 4175-4178.
23. Weeks, Ott J, Lathrop GM. SLINK: A general simulation program for linkage analysis. Am J Hum Genet 1990; 47: A204.
24. Ott A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, Grobbee DE et al. Prevalence of Alzheimer's disease and vascular dementia: Association with education. The Rotterdam study. BMJ 1995; 310: 970-973.
25. Lathrop GM, Lalouel JM, Juliet C, Ott J. Multilocus linkage analysis in humans: Detection of linkage and estimation of recombination. Am J Hum Genet 1985; 37: 482-498.
26. Poorkaj P, Kas A, D'Souza I, Zhou Y, Pham Q, Stone M et al. A genomic sequence analysis of the mouse and human microtubule-associated protein tau. Mamm Genome 2001; 12: 700-712.
27. Rosso SM, Kamphorst W, de Graaf B, Willemsen R, Ravid R, Niermeijer MF et al. Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. Brain 2001; 124: 1948-1957.
28. Woulfe J, Kertesz A, Munoz DG. Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions. Acta Neuropathol (Berl) 2001; 102: 94-102.
29. Wei ML, Andreadis A. Splicing of a regulated exon reveals additional complexity in the axonal microtubule-associated protein tau. J Neurochem 1998; 70: 1346-1356.
30. Chen WT, Liu WK, Yen SH. Expression of tau exon 8 in different species. Neurosci Lett 1994; 172: 167-170.
31. Taleghany N, Oblinger MM. Regional distribution and biochemical characteristics of high molecular weight tau in the nervous system. J Neurosci Res 1992; 33: 257-265.
32. Goedert M, Spillantini MG, Crowther RA. Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system. Proc Natl Acad Sci U S A 1992; 89: 1983-1987.
33. Georgieff IS, Liem RK, Mellado W, Nunez J, Shelanski ML. High molecular weight tau: Preferential localization in the peripheral nervous system. J Cell Sci 1991; 100: 55-60.
34. Heicklen-Klein A, Ginzburg I. Tau promoter confers neuronal specificity and binds Sp1 and AP-2. J Neurochem 2000; 75: 1408-1418.
35. Ezquerra M, Pastor P, Valldeoriola F, Molinuevo JL, Blesa R, Tolosa E et al. Identification of a novel polymorphism in the promoter region of the tau gene highly associated to progressive supranuclear palsy in humans. Neurosci Lett 1999; 275: 183-186.
36. Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 1999; 8: 711-715.
37. de Silva R, Weiler M, Morris HR, Martin ER, Wood NW, Lees AJ. Strong association of a novel Tau promoter haplotype in progressive supranuclear palsy. Neurosci Lett 2001; 311: 145-148.
38. Higgins JJ, Golbe LI, De Biase A, Jankovic J, Factor SA, Adler RL. An extended 5′-tau susceptibility haplotype in progressive supranuclear palsy. Neurology 2000; 55: 1364-1367.
39. Houlden H, Baker M, Morris HR, MacDonald N, Pickering-Brown S, Adamson J et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 2001; 56: 1702-1706.
40. Poorkaj P, Tsuang D, Wijsman E, Steinbart E, Garruto RM, Craig UK et al. TAU as a susceptibility gene for amyotropic lateral sclerosis-parkinsonism dementia complex of Guam. Arch Neurol 2001; 58: 1871-1878.
41. Foster NL, Wilhelmsen K, Sima AA, Jones MZ, D'Amato CJ, Gilman S. Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference. Conference participants. Ann Neurol 1997; 41: 706-715.
42. Lendon CL, Lynch T, Norton J, McKeel DW Jr, Busfield F, Craddock N et al. Hereditary dysphasic disinhibition dementia: A frontotemporal dementia linked to 17q21-22. Neurology 1998; 50: 1546-1555.
43. Basun H, Almkvist O, Axelman K, Brun A, Campbell TA, Collinge J et al. Clinical characteristics of a chromosome 17-linked rapidly progressive familial frontotemporal dementia. Arch Neurol 1997; 54: 539-544.
44. Bird TD, Wijsman EM, Nochlin D, Leehey M, Sumi SM, Payami H et al. Chromosome 17 and hereditary dementia: Linkage studies in three non-Alzheimer families and kindreds with late-onset FAD. Neurology 1997; 48: 949-954.
45. Froelich S, Basun H, Forsell C, Lilius L, Axelman K, Andreadis A et al. Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12-21. Am J Med Genet 1997; 74: 380-385.
46. Conrad C, Vianna C, Davies P. Saitohin, a novel putative gene in the tau locus. Soc Neurosci Abstr 2001; 27: Program No. 542.6.
47. Zhukareva V, Vogelsberg-Ragaglia V, Van Deerlin VM, Bruce J, Shuck T, Grossman M et al. Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia. Ann Neurol 2001; 49: 165-175.